Invitrogen™ Silencer™ Human Drug Targets siRNA Library (96 well)

Description

The Silencer™ Human Drug Targets siRNA Library includes genes involved in apoptosis, senescence, nucleic acid binding, autophagy, DNA repair, and along with characterized nuclear receptors and other genes that are considered potential targets for therapeutics. The Silencer Human Drug Targets siRNA Library contains 23,745 Ambion™ Silencer siRNAs targeting 7,915 genes for performing RNAi screens against known human drug target genes. The library was designed using the most up-to-date genome databases, including the NCBI RefSeq database and cross-referenced to the Gene Ontology Consortium (GO) database and/or the HUGO Gene Nomenclature Committee (HGNC).

Why use the Silencer Human Drug Targets siRNA Library?Together with careful bioinformatics selection of gene targets, Silencer siRNAs are optimized for design and high quality synthesis with guaranteed silencing. The Silencer Human Drug Targets siRNA Library contains our pre-designed and when available, validated siRNAs generated with maximum potency and specificity in mind so you can focus on data quality. All Silencer libraries are selected against the latest available databases and resources for up-to-date content. Full siRNA sequence information, as well as the exon targeted and each targeted gene's symbol, full name, aliases, RefSeq number, and Locus ID, plus results from any validation experiments performed using the included siRNAs is provided. Please contact us for the complete list of targets.Silencer siRNA libraries allow you to screen efficiently and maximize data outputInvitrogen Silencer siRNAs are designed with potency in mind to help ensure gene knockdown at minimum concentrations. This not only helps to ensure less potential for off target effects and false positive data but also minimizes false negative outcomes of siRNA screening. The Silencer Human Drug Targets siRNA Library contains 0.25 nmol of each siRNA, sufficient for 100 transfections (at 25 nM siRNA, 100 μL transfection volume).
Utilizing Invitrogen Silencer technology built on stringent bioinformatics to enable high target specificity and siRNA potency, the Silencer Human Drug Targets siRNA Library is an ideal solution for focused and cost-effective RNAi screening against pre-defined therapeutic gene drug targets .

• Comprehensive—Expedite your drug target screens with pre-defined libraries of Silencer human drug targets siRNAs
• Reliable—Increase target screening accuracy with three individual siRNAs per gene targetEffective—Reduce off target impacts at low concentrations with proven Invitrogen Silencer siRNA design
• Convenient—Reduce data de-convolution and accelerate target validation with our 96-and 384-well arrayed format
• Customizable—Choose the best option for your workflow demands, including additional siRNA scales and pooled formats